- call +1-201-465-4211
- email sales@mrinsights.biz
According to this latest study, the 2021 growth of Tumor Immunotherapy will have significant change from previous year. By the most conservative estimates of global Tumor Immunotherapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Tumor Immunotherapy market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Tumor Immunotherapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Tumor Infiltrating Lymphocyte (TIL) Treatment
Engineered T Cell Receptor (TCR) Therapy
Chimeric Antigen Receptor (CAR) T Cell Therapy
Natural Killer (NK) Cell Therapy
Other
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Biopharmaceutical Company
Hospital
Universities And Other Scientific Research Institutions
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Roche
Merck
Novartis
Johnson & Johnson
GlaxoSmithKline
AbbVie
ELI Lilly
Amgen
AstraZeneca
Bristol-Mysers Squibb
Kite Pharma
Adaptimmune
Altor Bioscience Corporation
Cellectis
Juno Therapeutics
Takara Bio
Unum Therapeutics
Sunway
Junshi Bio
Cinda Bio
BeiGene
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tumor Immunotherapy Market Size 2016-2026
2.1.2 Tumor Immunotherapy Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Tumor Immunotherapy Segment by Type
2.2.1 Tumor Infiltrating Lymphocyte (TIL) Treatment
2.2.2 Tumor Infiltrating Lymphocyte (TIL) Treatment
2.2.3 Chimeric Antigen Receptor (CAR) T Cell Therapy
2.2.4 Natural Killer (NK) Cell Therapy
2.2.5 Other
2.3 Tumor Immunotherapy Market Size by Type
2.3.1 Global Tumor Immunotherapy Market Size CAGR by Type
2.3.2 Global Tumor Immunotherapy Market Size Market Share by Type (2016-2021)
2.4 Tumor Immunotherapy Segment by Application
2.4.1 Biopharmaceutical Company
2.4.2 Hospital
2.4.3 Universities And Other Scientific Research Institutions
2.4.4 Other
2.5 Tumor Immunotherapy Market Size by Application
2.5.1 Global Tumor Immunotherapy Market Size CAGR by Application
2.5.2 Global Tumor Immunotherapy Market Size Market Share by Application (2016-2021)
3 Tumor Immunotherapy Market Size by Players
3.1 Tumor Immunotherapy Market Size Market Share by Players
3.1.1 Global Tumor Immunotherapy Revenue by Players (2019-2021E)
3.1.2 Global Tumor Immunotherapy Revenue Market Share by Players (2019-2021E)
3.2 Global Tumor Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Tumor Immunotherapy by Regions
4.1 Tumor Immunotherapy Market Size by Regions (2016-2021)
4.2 Americas Tumor Immunotherapy Market Size Growth (2016-2021)
4.3 APAC Tumor Immunotherapy Market Size Growth (2016-2021)
4.4 Europe Tumor Immunotherapy Market Size Growth (2016-2021)
4.5 Middle East & Africa Tumor Immunotherapy Market Size Growth (2016-2021)
5 Americas
5.1 Americas Tumor Immunotherapy Market Size by Country (2016-2021)
5.2 Americas Tumor Immunotherapy Market Size by Type (2016-2021)
5.3 Americas Tumor Immunotherapy Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tumor Immunotherapy Market Size by Region (2016-2021)
6.2 APAC Tumor Immunotherapy Market Size by Type (2016-2021)
6.3 APAC Tumor Immunotherapy Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Tumor Immunotherapy by Country (2016-2021)
7.2 Europe Tumor Immunotherapy Market Size by Type (2016-2021)
7.3 Europe Tumor Immunotherapy Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tumor Immunotherapy by Region (2016-2021)
8.2 Middle East & Africa Tumor Immunotherapy Market Size by Type (2016-2021)
8.3 Middle East & Africa Tumor Immunotherapy Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Tumor Immunotherapy Market Forecast
10.1 Global Tumor Immunotherapy Forecast by Regions (2021-2026)
10.1.1 Global Tumor Immunotherapy Forecast by Regions (2021-2026)
10.1.2 Americas Tumor Immunotherapy Forecast
10.1.3 APAC Tumor Immunotherapy Forecast
10.1.4 Europe Tumor Immunotherapy Forecast
10.1.5 Middle East & Africa Tumor Immunotherapy Forecast
10.2 Americas Tumor Immunotherapy Forecast by Countries (2021-2026)
10.2.1 United States Tumor Immunotherapy Market Forecast
10.2.2 Canada Tumor Immunotherapy Market Forecast
10.2.3 Mexico Tumor Immunotherapy Market Forecast
10.2.4 Brazil Tumor Immunotherapy Market Forecast
10.3 APAC Tumor Immunotherapy Forecast by Region (2021-2026)
10.3.1 China Tumor Immunotherapy Market Forecast
10.3.2 Japan Tumor Immunotherapy Market Forecast
10.3.3 Korea Tumor Immunotherapy Market Forecast
10.3.4 Southeast Asia Tumor Immunotherapy Market Forecast
10.3.5 India Tumor Immunotherapy Market Forecast
10.3.6 Australia Tumor Immunotherapy Market Forecast
10.4 Europe Tumor Immunotherapy Forecast by Country (2021-2026)
10.4.1 Germany Tumor Immunotherapy Market Forecast
10.4.2 France Tumor Immunotherapy Market Forecast
10.4.3 UK Tumor Immunotherapy Market Forecast
10.4.4 Italy Tumor Immunotherapy Market Forecast
10.4.5 Russia Tumor Immunotherapy Market Forecast
10.5 Middle East & Africa Tumor Immunotherapy Forecast by Region (2021-2026)
10.5.1 Egypt Tumor Immunotherapy Market Forecast
10.5.2 South Africa Tumor Immunotherapy Market Forecast
10.5.3 Israel Tumor Immunotherapy Market Forecast
10.5.4 Turkey Tumor Immunotherapy Market Forecast
10.5.5 GCC Countries Tumor Immunotherapy Market Forecast
10.6 Global Tumor Immunotherapy Forecast by Type (2021-2026)
10.8 Global Tumor Immunotherapy Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Tumor Immunotherapy Product Offered
11.1.3 Roche Tumor Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Tumor Immunotherapy Product Offered
11.2.3 Merck Tumor Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Merck Main Business Overview
11.2.5 Merck Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Tumor Immunotherapy Product Offered
11.3.3 Novartis Tumor Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Tumor Immunotherapy Product Offered
11.4.3 Johnson & Johnson Tumor Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Tumor Immunotherapy Product Offered
11.5.3 GlaxoSmithKline Tumor Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 GlaxoSmithKline Main Business Overview
11.5.5 GlaxoSmithKline Latest Developments
11.6 AbbVie
11.6.1 AbbVie Company Information
11.6.2 AbbVie Tumor Immunotherapy Product Offered
11.6.3 AbbVie Tumor Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 AbbVie Main Business Overview
11.6.5 AbbVie Latest Developments
11.7 ELI Lilly
11.7.1 ELI Lilly Company Information
11.7.2 ELI Lilly Tumor Immunotherapy Product Offered
11.7.3 ELI Lilly Tumor Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 ELI Lilly Main Business Overview
11.7.5 ELI Lilly Latest Developments
11.8 Amgen
11.8.1 Amgen Company Information
11.8.2 Amgen Tumor Immunotherapy Product Offered
11.8.3 Amgen Tumor Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Amgen Main Business Overview
11.8.5 Amgen Latest Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Company Information
11.9.2 AstraZeneca Tumor Immunotherapy Product Offered
11.9.3 AstraZeneca Tumor Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 AstraZeneca Main Business Overview
11.9.5 AstraZeneca Latest Developments
11.10 Bristol-Mysers Squibb
11.10.1 Bristol-Mysers Squibb Company Information
11.10.2 Bristol-Mysers Squibb Tumor Immunotherapy Product Offered
11.10.3 Bristol-Mysers Squibb Tumor Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Bristol-Mysers Squibb Main Business Overview
11.10.5 Bristol-Mysers Squibb Latest Developments
11. Kite Pharma
11.11.1 Kite Pharma Company Information
11.11.2 Kite Pharma Tumor Immunotherapy Product Offered
11.11.3 Kite Pharma Tumor Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Kite Pharma Main Business Overview
11.11.5 Kite Pharma Latest Developments
11.12 Adaptimmune
11.12.1 Adaptimmune Company Information
11.12.2 Adaptimmune Tumor Immunotherapy Product Offered
11.12.3 Adaptimmune Tumor Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Adaptimmune Main Business Overview
11.12.5 Adaptimmune Latest Developments
11.13 Altor Bioscience Corporation
11.13.1 Altor Bioscience Corporation Company Information
11.13.2 Altor Bioscience Corporation Tumor Immunotherapy Product Offered
11.13.3 Altor Bioscience Corporation Tumor Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Altor Bioscience Corporation Main Business Overview
11.13.5 Altor Bioscience Corporation Latest Developments
11.14 Cellectis
11.14.1 Cellectis Company Information
11.14.2 Cellectis Tumor Immunotherapy Product Offered
11.14.3 Cellectis Tumor Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Cellectis Main Business Overview
11.14.5 Cellectis Latest Developments
11.15 Juno Therapeutics
11.15.1 Juno Therapeutics Company Information
11.15.2 Juno Therapeutics Tumor Immunotherapy Product Offered
11.15.3 Juno Therapeutics Tumor Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Juno Therapeutics Main Business Overview
11.15.5 Juno Therapeutics Latest Developments
11.16 Takara Bio
11.16.1 Takara Bio Company Information
11.16.2 Takara Bio Tumor Immunotherapy Product Offered
11.16.3 Takara Bio Tumor Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 Takara Bio Main Business Overview
11.16.5 Takara Bio Latest Developments
11.17 Unum Therapeutics
11.17.1 Unum Therapeutics Company Information
11.17.2 Unum Therapeutics Tumor Immunotherapy Product Offered
11.17.3 Unum Therapeutics Tumor Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
11.17.4 Unum Therapeutics Main Business Overview
11.17.5 Unum Therapeutics Latest Developments
11.18 Sunway
11.18.1 Sunway Company Information
11.18.2 Sunway Tumor Immunotherapy Product Offered
11.18.3 Sunway Tumor Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
11.18.4 Sunway Main Business Overview
11.18.5 Sunway Latest Developments
11.19 Junshi Bio
11.19.1 Junshi Bio Company Information
11.19.2 Junshi Bio Tumor Immunotherapy Product Offered
11.19.3 Junshi Bio Tumor Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
11.19.4 Junshi Bio Main Business Overview
11.19.5 Junshi Bio Latest Developments
11.20 Cinda Bio
11.20.1 Cinda Bio Company Information
11.20.2 Cinda Bio Tumor Immunotherapy Product Offered
11.20.3 Cinda Bio Tumor Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
11.20.4 Cinda Bio Main Business Overview
11.20.5 Cinda Bio Latest Developments
11.21 BeiGene
11.21.1 BeiGene Company Information
11.21.2 BeiGene Tumor Immunotherapy Product Offered
11.21.3 BeiGene Tumor Immunotherapy Revenue, Gross Margin and Market Share (2019-2021)
11.21.4 BeiGene Main Business Overview
11.21.5 BeiGene Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Tumor Immunotherapy Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Tumor Infiltrating Lymphocyte (TIL) Treatment
Table 3. Major Players of Engineered T Cell Receptor (TCR) Therapy
Table 4. Major Players of Chimeric Antigen Receptor (CAR) T Cell Therapy
Table 5. Major Players of Natural Killer (NK) Cell Therapy
Table 6. Major Players of Other
Table 7. Tumor Immunotherapy Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 8. Global Tumor Immunotherapy Market Size by Type (2016-2021) & ($ Millions)
Table 9. Global Tumor Immunotherapy Market Size Market Share by Type (2016-2021)
Table 10. Tumor Immunotherapy Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 11. Global Tumor Immunotherapy Market Size by Application (2016-2021) & ($ Millions)
Table 12. Global Tumor Immunotherapy Market Size Market Share by Application (2016-2021)
Table 13. Global Tumor Immunotherapy Revenue by Players (2019-2021E) & ($ Millions)
Table 14. Global Tumor Immunotherapy Revenue Market Share by Players (2019-2021E)
Table 15. Tumor Immunotherapy Key Players Head office and Products Offered
Table 16. Tumor Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Tumor Immunotherapy Market Size by Regions 2016-2021 & ($ Millions)
Table 20. Global Tumor Immunotherapy Market Size Market Share by Regions 2016-2021
Table 21. Americas Tumor Immunotherapy Market Size by Country (2016-2021) & ($ Millions)
Table 22. Americas Tumor Immunotherapy Market Size Market Share by Country (2016-2021)
Table 23. Americas Tumor Immunotherapy Market Size by Type (2016-2021) & ($ Millions)
Table 24. Americas Tumor Immunotherapy Market Size Market Share by Type (2016-2021)
Table 25. Americas Tumor Immunotherapy Market Size by Application (2016-2021) & ($ Millions)
Table 26. Americas Tumor Immunotherapy Market Size Market Share by Application (2016-2021)
Table 27. APAC Tumor Immunotherapy Market Size by Region (2016-2021) & ($ Millions)
Table 28. APAC Tumor Immunotherapy Market Size Market Share by Region (2016-2021)
Table 29. APAC Tumor Immunotherapy Market Size by Type (2016-2021) & ($ Millions)
Table 30. APAC Tumor Immunotherapy Market Size Market Share by Type (2016-2021)
Table 31. APAC Tumor Immunotherapy Market Size by Application (2016-2021) & ($ Millions)
Table 32. APAC Tumor Immunotherapy Market Size Market Share by Application (2016-2021)
Table 33. Europe Tumor Immunotherapy Market Size by Country (2016-2021) & ($ Millions)
Table 34. Europe Tumor Immunotherapy Market Size Market Share by Country (2016-2021)
Table 35. Europe Tumor Immunotherapy Market Size by Type (2016-2021) & ($ Millions)
Table 36. Europe Tumor Immunotherapy Market Size Market Share by Type (2016-2021)
Table 37. Europe Tumor Immunotherapy Market Size by Application (2016-2021) & ($ Millions)
Table 38. Europe Tumor Immunotherapy Market Size Market Share by Application (2016-2021)
Table 39. Middle East & Africa Tumor Immunotherapy Market Size by Region (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Tumor Immunotherapy Market Size Market Share by Region (2016-2021)
Table 41. Middle East & Africa Tumor Immunotherapy Market Size by Type (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Tumor Immunotherapy Market Size Market Share by Type (2016-2021)
Table 43. Middle East & Africa Tumor Immunotherapy Market Size by Application (2016-2021) & ($ Millions)
Table 44. Middle East & Africa Tumor Immunotherapy Market Size Market Share by Application (2016-2021)
Table 45. Key and Potential Regions of Tumor Immunotherapy
Table 46. Key Application and Potential Industries of Tumor Immunotherapy
Table 47. Key Challenges of Tumor Immunotherapy
Table 48. Key Trends of Tumor Immunotherapy
Table 49. Global Tumor Immunotherapy Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 50. Global Tumor Immunotherapy Market Size Market Share Forecast by Regions (2021-2026)
Table 51. Global Tumor Immunotherapy Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 52. Global Tumor Immunotherapy Market Size Market Share Forecast by Type (2021-2026)
Table 53. Global Tumor Immunotherapy Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 54. Global Tumor Immunotherapy Market Size Market Share Forecast by Application (2021-2026)
Table 55. Roche Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
Table 56. Roche Tumor Immunotherapy Product Offered
Table 57. Roche Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 58. Roche Main Business
Table 59. Roche Latest Developments
Table 60. Merck Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
Table 61. Merck Tumor Immunotherapy Product Offered
Table 62. Merck Main Business
Table 63. Merck Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 64. Merck Latest Developments
Table 65. Novartis Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
Table 66. Novartis Tumor Immunotherapy Product Offered
Table 67. Novartis Main Business
Table 68. Novartis Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 69. Novartis Latest Developments
Table 70. Johnson & Johnson Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
Table 71. Johnson & Johnson Tumor Immunotherapy Product Offered
Table 72. Johnson & Johnson Main Business
Table 73. Johnson & Johnson Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 74. Johnson & Johnson Latest Developments
Table 75. GlaxoSmithKline Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
Table 76. GlaxoSmithKline Tumor Immunotherapy Product Offered
Table 77. GlaxoSmithKline Main Business
Table 78. GlaxoSmithKline Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 79. GlaxoSmithKline Latest Developments
Table 80. AbbVie Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
Table 81. AbbVie Tumor Immunotherapy Product Offered
Table 82. AbbVie Main Business
Table 83. AbbVie Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 84. AbbVie Latest Developments
Table 85. ELI Lilly Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
Table 86. ELI Lilly Tumor Immunotherapy Product Offered
Table 87. ELI Lilly Main Business
Table 88. ELI Lilly Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 89. ELI Lilly Latest Developments
Table 90. Amgen Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
Table 91. Amgen Tumor Immunotherapy Product Offered
Table 92. Amgen Main Business
Table 93. Amgen Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 94. Amgen Latest Developments
Table 95. AstraZeneca Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
Table 96. AstraZeneca Tumor Immunotherapy Product Offered
Table 97. AstraZeneca Main Business
Table 98. AstraZeneca Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 99. AstraZeneca Latest Developments
Table 100. Bristol-Mysers Squibb Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
Table 101. Bristol-Mysers Squibb Tumor Immunotherapy Product Offered
Table 102. Bristol-Mysers Squibb Main Business
Table 103. Bristol-Mysers Squibb Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 104. Bristol-Mysers Squibb Latest Developments
Table 105. Kite Pharma Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
Table 106. Kite Pharma Tumor Immunotherapy Product Offered
Table 107. Kite Pharma Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 108. Kite Pharma Main Business
Table 109. Kite Pharma Latest Developments
Table 110. Adaptimmune Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
Table 111. Adaptimmune Tumor Immunotherapy Product Offered
Table 112. Adaptimmune Main Business
Table 113. Adaptimmune Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 114. Adaptimmune Latest Developments
Table 115. Altor Bioscience Corporation Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
Table 116. Altor Bioscience Corporation Tumor Immunotherapy Product Offered
Table 117. Altor Bioscience Corporation Main Business
Table 118. Altor Bioscience Corporation Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 119. Altor Bioscience Corporation Latest Developments
Table 120. Cellectis Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
Table 121. Cellectis Tumor Immunotherapy Product Offered
Table 122. Cellectis Main Business
Table 123. Cellectis Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 124. Cellectis Latest Developments
Table 125. Juno Therapeutics Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
Table 126. Juno Therapeutics Tumor Immunotherapy Product Offered
Table 127. Juno Therapeutics Main Business
Table 128. Juno Therapeutics Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 129. Juno Therapeutics Latest Developments
Table 130. Takara Bio Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
Table 131. Takara Bio Tumor Immunotherapy Product Offered
Table 132. Takara Bio Main Business
Table 133. Takara Bio Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 134. Takara Bio Latest Developments
Table 135. Unum Therapeutics Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
Table 136. Unum Therapeutics Tumor Immunotherapy Product Offered
Table 137. Unum Therapeutics Main Business
Table 138. Unum Therapeutics Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 139. Unum Therapeutics Latest Developments
Table 140. Sunway Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
Table 141. Sunway Tumor Immunotherapy Product Offered
Table 142. Sunway Main Business
Table 143. Sunway Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 144. Sunway Latest Developments
Table 145. Junshi Bio Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
Table 146. Junshi Bio Tumor Immunotherapy Product Offered
Table 147. Junshi Bio Main Business
Table 148. Junshi Bio Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 149. Junshi Bio Latest Developments
Table 150. Cinda Bio Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
Table 151. Cinda Bio Tumor Immunotherapy Product Offered
Table 152. Cinda Bio Main Business
Table 153. Cinda Bio Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 154. Cinda Bio Latest Developments
Table 155. BeiGene Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors
Table 156. BeiGene Tumor Immunotherapy Product Offered
Table 157. BeiGene Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 158. BeiGene Main Business
Table 159. BeiGene Latest Developments
List of Figures
Figure 1. Tumor Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tumor Immunotherapy Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Tumor Immunotherapy Market Size Market Share by Type in 2020
Figure 7. Tumor Immunotherapy in Biopharmaceutical Company
Figure 8. Global Tumor Immunotherapy Market: Biopharmaceutical Company (2016-2021) & ($ Millions)
Figure 9. Tumor Immunotherapy in Hospital
Figure 10. Global Tumor Immunotherapy Market: Hospital (2016-2021) & ($ Millions)
Figure 11. Tumor Immunotherapy in Universities And Other Scientific Research Institutions
Figure 12. Global Tumor Immunotherapy Market: Universities And Other Scientific Research Institutions (2016-2021) & ($ Millions)
Figure 13. Tumor Immunotherapy in Other
Figure 14. Global Tumor Immunotherapy Market: Other (2016-2021) & ($ Millions)
Figure 15. Global Tumor Immunotherapy Market Size Market Share by Application in 2020
Figure 16. Global Tumor Immunotherapy Revenue Market Share by Player in 2020
Figure 17. Global Tumor Immunotherapy Market Size Market Share by Regions (2016-2021)
Figure 18. Americas Tumor Immunotherapy Market Size 2016-2021 ($ Millions)
Figure 19. APAC Tumor Immunotherapy Market Size 2016-2021 ($ Millions)
Figure 20. Europe Tumor Immunotherapy Market Size 2016-2021 ($ Millions)
Figure 21. Middle East & Africa Tumor Immunotherapy Market Size 2016-2021 ($ Millions)
Figure 22. Americas Tumor Immunotherapy Market Size Market Share by Country in 2020
Figure 23. Americas Tumor Immunotherapy Market Size Market Share by Type in 2020
Figure 24. Americas Tumor Immunotherapy Market Size Market Share by Application in 2020
Figure 25. United States Tumor Immunotherapy Market Size Growth 2016-2021 ($ Millions)
Figure 26. Canada Tumor Immunotherapy Market Size Growth 2016-2021 ($ Millions)
Figure 27. Mexico Tumor Immunotherapy Market Size Growth 2016-2021 ($ Millions)
Figure 28. APAC Tumor Immunotherapy Market Size Market Share by Regions in 2020
Figure 29. APAC Tumor Immunotherapy Market Size Market Share by Type in 2020
Figure 30. APAC Tumor Immunotherapy Market Size Market Share by Application in 2020
Figure 31. China Tumor Immunotherapy Market Size Growth 2016-2021 ($ Millions)
Figure 32. Japan Tumor Immunotherapy Market Size Growth 2016-2021 ($ Millions)
Figure 33. Korea Tumor Immunotherapy Market Size Growth 2016-2021 ($ Millions)
Figure 34. Southeast Asia Tumor Immunotherapy Market Size Growth 2016-2021 ($ Millions)
Figure 35. India Tumor Immunotherapy Market Size Growth 2016-2021 ($ Millions)
Figure 36. Australia Tumor Immunotherapy Market Size Growth 2016-2021 ($ Millions)
Figure 37. Europe Tumor Immunotherapy Market Size Market Share by Country in 2020
Figure 38. Europe Tumor Immunotherapy Market Size Market Share by Type in 2020
Figure 39. Europe Tumor Immunotherapy Market Size Market Share by Application in 2020
Figure 40. Germany Tumor Immunotherapy Market Size Growth 2016-2021 ($ Millions)
Figure 41. France Tumor Immunotherapy Market Size Growth 2016-2021 ($ Millions)
Figure 42. UK Tumor Immunotherapy Market Size Growth 2016-2021 ($ Millions)
Figure 43. Italy Tumor Immunotherapy Market Size Growth 2016-2021 ($ Millions)
Figure 44. Russia Tumor Immunotherapy Market Size Growth 2016-2021 ($ Millions)
Figure 45. Middle East & Africa Tumor Immunotherapy Market Size Market Share by Region in 2020
Figure 46. Middle East & Africa Tumor Immunotherapy Market Size Market Share by Type in 2020
Figure 47. Middle East & Africa Tumor Immunotherapy Market Size Market Share by Application in 2020
Figure 48. Egypt Tumor Immunotherapy Market Size Growth 2016-2021 ($ Millions)
Figure 49. South Africa Tumor Immunotherapy Market Size Growth 2016-2021 ($ Millions)
Figure 50. Israel Tumor Immunotherapy Market Size Growth 2016-2021 ($ Millions)
Figure 51. Turkey Tumor Immunotherapy Market Size Growth 2016-2021 ($ Millions)
Figure 52. GCC Country Tumor Immunotherapy Market Size Growth 2016-2021 ($ Millions)
Figure 53. Americas Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
Figure 54. APAC Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
Figure 55. Europe Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
Figure 56. Middle East & Africa Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
Figure 57. United States Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
Figure 58. Canada Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
Figure 59. Mexico Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
Figure 60. Brazil Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
Figure 61. China Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
Figure 62. Japan Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
Figure 63. Korea Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
Figure 64. Southeast Asia Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
Figure 65. India Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
Figure 66. Australia Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
Figure 67. Germany Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
Figure 68. France Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
Figure 69. UK Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
Figure 70. Italy Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
Figure 71. Russia Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
Figure 72. Spain Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
Figure 73. Egypt Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
Figure 74. South Africa Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
Figure 75. Israel Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
Figure 76. Turkey Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
Figure 77. GCC Country Tumor Immunotherapy Market Size 2021-2026 ($ Millions)
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
